Development and validation of a high-performance liquid chromatography method for the quantification of talazoparib in rat plasma: Application to plasma protein binding studies-Reference-Cited by-同舟云学术

Development and validation of a high-performance liquid chromatography method for the quantification of talazoparib in rat plasma: Application to plasma protein binding studies

Published:2017-08-15 Issue:2 Volume:32 Page:e4046
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Hidau Mahendra Kumar¹^ORCID,Kolluru Srikanth²,Palakurthi Srinath¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy; Texas A&M Health Science Center; Kingsville Texas USA

2. Department of Pharmaceutical Sciences; KGI School of Pharmacy, Claremont; California Texas USA

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bmc.4046/fullpdf

Reference23 articles.

1. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid;Barre;Clinical Chemistry,1985

2. Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase;Bryant;Nature,2005

3. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics;Engert;Oncotarget,2016

4. Liquid chromatographic-tandem mass spectrometry assay for quantitation of a novel antidiabetic S002-853 in rat plasma and its application to pharmacokinetic study;Gautam;Biomedical Chromatography,2010

5. Calculation of drug concentration in plasma after equilibrium dialysis;Giacomini;British Journal of Clinical Pharmacology,1982

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an RP-HPLC method to evaluate the basic characteristics of talazoparib-loaded PLGA nanoparticles;Journal of Chemical Metrology;2024-06-28

2. Smart and sensitive nanomaterial-based electrochemical sensor for the determination of a poly (ADP-ribose) polymerase (PARP) inhibitor anticancer agent;Environmental Research;2023-12

3. Novel LC–MS Method development and Validation for Characterization of Talazoparib, an Anti-cancer drug and its forced degradation behavior;Research Journal of Pharmacy and Technology;2022-06-28

4. Recent Upgradation in Bioanalytical Studies;Biosciences Biotechnology Research Asia;2022-03-31

5. Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition;British Journal of Cancer;2021-01-21